KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure
The KidneyCell II Clinical Trial will feature non-invasive bioelectric stimulation controlled release of the Klotho protein known to be beneficial in kidney health Topline Data Expected in 4Q 2020 Irvine, CA and Porto Allegre, Brazil - February 17th, 2020...
KidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430%
Published: Mar 13, 2019 Device, programmed bioelectric signaling sequences and methods for the controlled expression of Klotho on demand Leonhardt's Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup accelerator focused on...
Leonhardt’s Launchpads Medtech Accelerator Expands into Pittsburgh
Leonhardt’s Launchpads, a medtech and biotech innovation and startup accelerator focused on organ regeneration and recovery technologies, today announced its expansion into Pittsburgh with the formation of Leonhardt’s Launchpads Pittsburgh. The company will be...
Leonhardt’s Launchpads Accelerator Announces Demo Days and Showcases September in San Francisco and Palo Alto for Organ Regeneration and Recovery Focused Startups
Leonhardt's Launchpads www.leonhardtventures.com an innovation and startup accelerator focused exclusively on organ and tissue regeneration and recovery technologies announced today Demo Days and Innovation Showcases to take place in San Francisco September 26th...
Leonhardt’s Launchpads Announces Filing of Patent for Bioelectric Stimulation Controlled Klotho Expression – Powerful anti-aging and Regeneration Promoting Protein
Device, programmed bioelectric signaling sequences and methods for the controlled expression of Klotho on demand via precise bioelectrical signaling sequences. Leonhardt's Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup...
KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure
The KidneyCell II Clinical Trial will feature non-invasive bioelectric stimulation controlled release of the Klotho protein known to be beneficial in kidney health Topline Data Expected in 4Q 2020 Irvine, CA and Porto Allegre, Brazil – February 17th, 2020...
Leonhardt’s Launchpads Announces Issuance of New U.S. Patent for Bioelectric Plus Biologics Platform for Organ Regeneration and Healing
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...